Your session is about to expire
← Back to Search
Test Group 3 for Pulse Oximetry (FAST 2024 Trial)
N/A
Waitlist Available
Research Sponsored by Philips Clinical & Medical Affairs Global
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up may-august 2024
Awards & highlights
Summary
Validation study to compare the accuracy of non-invasive Philips SpO2 sensors in detecting blood oxygen levels compared to invasive methods requiring a blood draw and lab analysis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ may-august 2024
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~may-august 2024
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
SpO2 Accuracy
Secondary study objectives
Non-Disparate Bias
Trial Design
4Treatment groups
Experimental Treatment
Group I: Test Group 4Experimental Treatment1 Intervention
* M1133A (989803205851)
* EX-M1133A (Experimental)
* M1196T (989803205911)
* EX-M1196T (Experimental)
* M1191BL (989803144381) as an internal reference only (optional)
Group II: Test Group 3Experimental Treatment1 Intervention
* EX-Alar on Nasal Ala (Experimental)
* EX-Alar on Ear (Experimental)
* M1191BL (989803144381) as an internal reference only
Group III: Test Group 2Experimental Treatment1 Intervention
* M1194A (989803205891)
* Alar (989803205381)
* M1191BL (989803144381) as an internal reference only
Group IV: Test Group 1Experimental Treatment1 Intervention
* M1131A (989803205831)
* M1191T (989803128591)
* M1191BL (989803144381) for endpoint analysis
* M1193A (989803205881)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
No Intervention
2017
Completed Phase 1
~4810
Find a Location
Who is running the clinical trial?
Philips Clinical & Medical Affairs GlobalLead Sponsor
53 Previous Clinical Trials
16,804 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger